Found: 6
Select item for more details and to access through your institution.
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 751, doi. 10.1093/rheumatology/kead284
- By:
- Publication type:
- Article
Conversion of the MDHAQ to the HAQ score: a simple algorithm developed and validated in a cohort of 13 391 real-world patients.
- Published in:
- Rheumatology, 2022, v. 61, n. 10, p. 3919, doi. 10.1093/rheumatology/keac040
- By:
- Publication type:
- Article
Sex Differences in the Effectiveness of First‐Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 4, p. 587, doi. 10.1002/art.42758
- By:
- Publication type:
- Article
Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03184-7
- By:
- Publication type:
- Article
Identification of the Tyrosine-Protein Phosphatase Non-Receptor Type 2 as a Rheumatoid Arthritis Susceptibility Locus in Europeans.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066456
- By:
- Publication type:
- Article
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
- Published in:
- Journal of Rheumatology, 2024, v. 51, n. 4, p. 378, doi. 10.3899/jrheum.2023-0764
- By:
- Publication type:
- Article